Health Insights | Volume 1, 2017

Exponent's scientists, physicians, and regulatory specialists provide unparalleled, interdisciplinary expertise to evaluate the full range of environmental, occupational, and public health issues that face our nation and the world. See what's been in the news lately, and how it may affect you, your company, and your clients.

EPA - Recent Regulatory Changes from the Federal Government

Toxic Substances Control Act (TSCA) - New Rules and Regulations Affecting Your Company

Product Stewardship - How Product Stewardship is Going Beyond Regulatory Compliance

  • The Business Case for Product Stewardship
    A company is best positioned when it understands its products holistically. Proactive approaches to product stewardship and chemical management make companies less vulnerable and prepared for any future challenge to their products’ integrity.
  • Looking Forward - The Next Generation of Product Stewardship

    In this case study, we highlight how Exponent helped a multinational company modernize their product sustainability program to encompass the health, ecological impact, and policies of their materials.

Health Fields - Updates from a Variety of Health Fields

  • Washington State Department of Health Finds No Increase in Cancer Risk Among Soccer Players Who Used artificial Turf Fields
    In light of public concerns about the possible effect of crumb rubber turf infill on cancer risk, the Washington State Department of Health and researchers from the University of Washington School of Public Health collaborated to conduct an investigation of cancer among soccer players compared with the general population, and to evaluate demographic and soccer-related risk factors among the cancer patients on the coach’s list.
  • Current Test Methods are Adequate for Identification of Endocrine Adverse Health Effects
    Exponent completed an independent comprehensive review of the current regulatory test methods and validated test guidelines for ability of test methods to collectively identify endocrine adverse health effects. Approximately 42 existing validated test methods and test guidelines were considered in the evaluation of coverage for endocrine-related adverse health effects, biological pathways and diseases using the adverse outcome pathway framework.
  • QSAR Testing and the New European Guidance on the Definition of the Residue

    The European Food Safety Authority (EFSA) has recently issued guidance on the establishment of the residue definition for dietary risk assessment of pesticides. In it, the process of DOR-setting is formalised by providing standard criteria to decide whether or not each metabolite should be included in the residue definition (for risk assessment; the residue definition for monitoring/enforcement is unaffected).

Exponent will be Presenting and Exhibiting:

Questions or comments? Please contact us